These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10812148)

  • 1. Use of antifibrinolytics in orthotopic liver transplantation.
    Kufner RP
    Transplant Proc; 2000 May; 32(3):636-7. PubMed ID: 10812148
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation.
    Kufner RP
    Liver Transpl Surg; 1997 Nov; 3(6):668-74; discussion 674-6. PubMed ID: 9404975
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifibrinolytics in orthotopic liver transplantation: current status and controversies.
    Xia VW; Steadman RH
    Liver Transpl; 2005 Jan; 11(1):10-8. PubMed ID: 15690531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio?
    Porte RJ
    Liver Transpl; 2004 Feb; 10(2):285-8. PubMed ID: 14762868
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
    Lerner AB
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifibrinolytics and orthotopic liver transplantation.
    Kufner RP
    Transplant Proc; 1998 May; 30(3):692-3. PubMed ID: 9595060
    [No Abstract]   [Full Text] [Related]  

  • 7. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival.
    Massicotte L; Denault AY; Beaulieu D; Thibeault L; Hevesi Z; Roy A
    Transplantation; 2011 Jun; 91(11):1273-8. PubMed ID: 21617589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation.
    Dalmau A; Sabaté A; Koo M; Rafecas A; Figueras J; Jaurrieta E
    Anesth Analg; 2001 Aug; 93(2):516. PubMed ID: 11473891
    [No Abstract]   [Full Text] [Related]  

  • 9. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Sansano T; Rafecas A; Figueras J; Jaurrieta E; Parrilla P
    Anesth Analg; 2000 Jul; 91(1):29-34. PubMed ID: 10866882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytics in liver transplantation.
    Groenland TH; Porte RJ
    Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
    [No Abstract]   [Full Text] [Related]  

  • 11. The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
    Badenoch A; Sharma A; Gower S; Selzner M; Srinivas C; Wąsowicz M; McCluskey SA
    Transplantation; 2017 Jul; 101(7):1658-1665. PubMed ID: 28187013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Zufferey P; Merquiol F; Laporte S; Decousus H; Mismetti P; Auboyer C; Samama CM; Molliex S
    Anesthesiology; 2006 Nov; 105(5):1034-46. PubMed ID: 17065899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic therapy and pulmonary thromboembolism during orthotopic liver transplantation.
    Parker BM; Irefin SA
    Anesth Analg; 2001 Feb; 92(2):559-60. PubMed ID: 11159274
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Reche M; Rafecas A; Figueras J; Jaurrieta E
    Transplant Proc; 1999 Sep; 31(6):2361-2. PubMed ID: 10500617
    [No Abstract]   [Full Text] [Related]  

  • 15. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
    Ramsay MA
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):891-3. PubMed ID: 17138102
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrinolytics.
    Schmarts
    Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
    [No Abstract]   [Full Text] [Related]  

  • 18. Con: Antifibrinolytics Should Not Be Used Routinely in Low-Risk Cardiac Surgery.
    Harvey R; Salehi A
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):248-51. PubMed ID: 26613643
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation, solvent-detergent treated plasma and antifibrinolytics.
    de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
    Anesth Analg; 2003 Apr; 96(4):1231-1232. PubMed ID: 12651692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.